Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence
about
sameAs
Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogensAntimicrobial peptides and the skin immune defense systemAlternative approaches to antifungal therapiesThe new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasisStructural and Functional Analysis of the Pro-Domain of Human Cathelicidin, LL-37Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureusChemerin is an antimicrobial agent in human epidermis.Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.Topical antimicrobials for burn infections - an updatePlatelets in defense against bacterial pathogens.Skin barrier functionExpression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection.Expression and activity of a novel cathelicidin from domestic cats.Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteasesLL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalentsOuter membrane lipoprotein Lpp is Gram-negative bacterial cell surface receptor for cationic antimicrobial peptidesLack of cathelicidin processing in Papillon-Lefèvre syndrome patients reveals essential role of LL-37 in periodontal homeostasisIncreased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea.An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiotaHuman cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity.Wound healing activity and mechanisms of action of an antibacterial protein from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus)Penicillin-binding protein 1a promotes resistance of group B streptococcus to antimicrobial peptides.M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition.A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media.Antimicrobial peptides and the skin.OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii.Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens.Stratum corneum defensive functions: an integrated view.Complex regulation of human cathelicidin gene expression: novel splice variants and 5'UTR negative regulatory element.Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune KillingVitamin D and the skin: an ancient friend, revisited.The role of cathelicidin and defensins in pulmonary inflammatory diseases.Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria.The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected WoundsThe role of antimicrobial peptides at the ocular surface.Antimicrobial peptides in human skin disease.Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanismsProduction and release of antimicrobial and immune defense proteins by mammary epithelial cells following Streptococcus uberis infection of sheep.Activation of cathepsin L by the cathelin-like domain of protegrin-3
P2860
Q24336171-8794EB94-3EA8-4F55-8493-9D23B82237D5Q24654981-B2DC41F4-EF12-4E09-A1B2-2F0FEC5CE46CQ26999896-9DA0BC90-7AD6-48A7-A006-A9C735A8DBFCQ27007680-38A6F28D-0CBD-47C9-80D1-3A435F6E8901Q27676356-5D8D49F5-9CDD-4CD3-8D47-31585042A171Q28395363-F5B2EBB3-0EB5-4002-AF3F-6DF985DFE5E9Q30032660-0CB95750-0710-4AF1-9C17-E2DE917D8DC8Q30490685-95EEF551-01E2-479D-B5DF-A9A0AA69349FQ33600002-FA8CB1D7-891E-4399-B688-993A3BAAFEEEQ33604443-C05533F2-D402-424D-8FED-2909E8F9B644Q33744906-2EAB2278-3533-42E5-9D5A-E36207A01361Q33858728-99C5C26E-4A24-4348-A4BF-CDDB4846101FQ33886915-F49B73D0-9E9F-4D39-90CC-AA6AC525C402Q34044666-B17C35AC-5FDE-45E0-A2F5-AD61C4ACE368Q34058299-720A8D4D-A22E-42EC-8E93-F28FBDD4F31CQ34074686-2DE961D8-842D-4A33-9A1E-3CAED1B55BE2Q34274507-0010415F-31C7-49F8-B51C-70BB9262D293Q34384434-38091608-5175-43ED-B974-990CACDEAA88Q34534186-6750EA55-EC93-4E51-B64B-423ACA48968DQ34647328-9725DD4E-96FC-4E56-9CF4-FA6D34871DE5Q34758057-53ED986D-2DB2-402E-BC86-0EC2F8C9829EQ35097174-B1AA9816-4F90-4298-8682-479E80C60E2EQ35217549-3D4D57CA-BB93-475C-8647-1314B0C25C35Q35621805-C549BFA8-BAAF-4362-9090-5E956245704AQ35672138-FF1F9E1E-D5C1-4EE6-A3DE-72BA5A4F8A34Q35753531-4063FF12-C00D-40F6-9E19-6302EAFA1B86Q35814247-376584E1-F4D1-40D6-BECE-6DB8967EA08CQ35963490-A97B0E81-C4B3-4714-9D14-F96A7656964EQ36228049-F447E9DE-A3D7-4A17-857B-5D00771B2023Q36238858-8F8C174A-E788-4C39-83FE-39B5B5A6B179Q36257995-AA8453AF-2B37-4114-87C6-A5FFD0CD7506Q36852095-31FB1023-1664-4EC3-BFD5-85633683CF0AQ36922272-554195FE-D22D-4A68-A30D-AC2AA5D443D6Q36932099-71982E55-BBBB-4BB6-83AE-1AD209B70E33Q36977156-216A697D-1281-43EA-A992-041E4FBD2B81Q37017370-88617F4B-B856-431F-A048-8FC2331D41C5Q37034707-CB7E25F8-9974-4B18-9A6F-5D98E8DC604EQ37105441-19C9491E-8B36-4C40-BDE3-EC7CC5B64BC4Q37123820-60FC3019-C8C3-43DA-8210-5A5FAC8F4B5CQ37195957-376A4B8E-9B0E-4097-A794-2551A7E2C936
P2860
Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antimicrobial and protease inh ...... din (hCAP18/LL-37) prosequence
@ast
Antimicrobial and protease inh ...... din (hCAP18/LL-37) prosequence
@en
Antimicrobial and protease inh ...... din (hCAP18/LL-37) prosequence
@nl
type
label
Antimicrobial and protease inh ...... din (hCAP18/LL-37) prosequence
@ast
Antimicrobial and protease inh ...... din (hCAP18/LL-37) prosequence
@en
Antimicrobial and protease inh ...... din (hCAP18/LL-37) prosequence
@nl
prefLabel
Antimicrobial and protease inh ...... din (hCAP18/LL-37) prosequence
@ast
Antimicrobial and protease inh ...... din (hCAP18/LL-37) prosequence
@en
Antimicrobial and protease inh ...... din (hCAP18/LL-37) prosequence
@nl
P1476
Antimicrobial and protease inh ...... din (hCAP18/LL-37) prosequence
@en
P2093
Richard L Gallo
P356
10.1046/J.1523-1747.2003.12132.X
P407
P577
2003-05-01T00:00:00Z
P5875
P6179
1006586442